Table 4.
Survival Rates of Patients based on Laboratory Results
| N | Median survival | P* | |
|---|---|---|---|
| Hb | |||
| <5 gr/dl | 18 | 3 (1-14) months | 0.501 |
| 5.1-10 gr/dl | 118 | 5 (1-17) months | |
| >10 gr/dl | 27 | 4 (1-15) months | |
| Leukocyte count | |||
| 3,500/mm3 | 0 | - | 0.634 |
| 3,500-12,000/mm3 | 57 | 6 (1-14) months | |
| 12,000-20,000/mm3 | 61 | 4 (1-17) months | |
| >20,000/mm3 | 45 | 4 (1-15) months | |
| Thrombocyte count | |||
| <150000 | 14 | 3 (1-8) months | 0.077 |
| 150000-450000 | 102 | 5 (1-14) months | |
| >450000 | 47 | 4 (1-17) months | |
| Blood Gas Analysis (pH) | |||
| Normal (7.35-7.45) | 112 | 5 (1-17) months | 0.687 |
| Metabolic Acidosis (<7.35) | 51 | 4 (1-15) months | |
| eGFR | |||
| Stage 1 | 0 | ||
| Stage 2 | 41 | 6 (1-17) months | 0.224 |
| Stage 3 | 44 | 5 (1-13) months | |
| Stage 4 | 37 | 4 (1-15) months | |
| Stage 5 | 41 | 4 (1-15) months | |
*Log-rank analysis